ETF Managers Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $207K | Buy |
31,789
+7,998
| +34% | +$52.1K | 0.01% | 581 |
|
|
2022
Q4 | $203K | Buy |
23,791
+13,323
| +127% | +$114K | 0.01% | 476 |
|
|
2022
Q3 | $55K | Sell |
10,468
-636
| -6% | -$3.34K | ﹤0.01% | 668 |
|
|
2022
Q2 | $49K | Buy |
11,104
+464
| +4% | +$2.05K | ﹤0.01% | 710 |
|
|
2022
Q1 | $37K | Buy |
10,640
+35
| +0.3% | +$122 | ﹤0.01% | 669 |
|
|
2021
Q4 | $70K | Sell |
10,605
-1,204
| -10% | -$7.95K | ﹤0.01% | 652 |
|
|
2021
Q3 | $125K | Buy |
11,809
+1,514
| +15% | +$16K | ﹤0.01% | 632 |
|
|
2021
Q2 | $325K | Sell |
10,295
-431
| -4% | -$13.6K | 0.01% | 583 |
|
|
2021
Q1 | $435K | Buy |
+10,726
| New | +$435K | 0.01% | 511 |
|